May 13, 2025
MantaBio Raises $2.5M Seed Round to Modernize Contamination Detection in Biopharma
We’re excited to share that MantaBio has raised $2.5 million in seed funding to accelerate development of our automated platform for microbial contamination detection in biologics manufacturing. Biologics represent one of the fastest-growing and most valuable segments in pharmaceuticals, generating over $400 billion annually. Yet despite decades of progress, most biopharma companies still rely on…
VIEW RELEASE